Nanjing Reju Therapeutics Co., Ltd

This early-stage study tests a new eye ointment called RC017 in 24 healthy adults aged 18 to 55. The goal is to see if the ointment is safe and how the body processes it after one or several doses. This is a first step before testing it in people with dry eye disease.

This early-phase study tests the safety and how the body handles a new inhaled drug called RC010 in 42 healthy adults. The drug is being developed for idiopathic pulmonary fibrosis (IPF), a serious lung-scarring disease. The study is not yet recruiting and focuses on side effects…